Skip to main content

Advertisement

Table 2 Treatment with Helixor® P and dose limiting toxicity (DLT)

From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Dose in mg Number of patients Treatment duration (weeks) DLT
200 3 3 No
400 3 3 No
700 3 3 No
1200 3 3 No
2000 3 3 Yes (patient 15)
2000 3 3 No
2000 3 9 No